Chinese infant formula manufacturer Synutra saw losses widen during the 2011 fiscal year, as it was hit by a food safety scandal earlier in the year.
Late yesterday (14 June), the group reported a US$40.1m net loss for the year ended 31 March, against a $24.6m net loss in the previous year.
Go deeper with GlobalData
During the company’s second quarter, unsubstantiated claims were made that its products caused premature breast growth in three infant girls.
Synutra chairman and CEO Liang Zhang said the company was “pleased to note” strong sequential growth recorded between the fourth and previous two quarters when it was impacted by the “hormone crisis”.
Fourth-quarter losses narrowed against the third quarter, down to US$8.5m against $11.9m in the third quarter. Losses also narrowed on a year-on-year basis, down on the $20.5m loss booked in the fourth-quarter of 2010.
On a quarter-on-quarter basis, sales were up 79.3% to reach $79.3m and up 79% on the fourth-quarter of 2010.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataBranded formula sales accounted for some 60.9% of net sales in the quarter against 46.8% of net sales in the third-quarter.
